These results from an uncontrolled study support the animal studies and prior reports showing that CBD may be a promising treatment for TRE and it is generally well-tolerated in doses up to 25mg/kg/day. Epidiolex is now being investigated in randomized controlled studies in DS and LGS.
Links
[1] https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/2414222
[2] http://www.rethinkpot.org/tags/charlottes-web
[3] http://www.rethinkpot.org/tags/american-epiliepsy-society
[4] http://www.rethinkpot.org/tags/aes
[5] http://www.rethinkpot.org/tags/study